BTR (Bitlayer) fluctuated 43.2% in 24 hours: surged to a high of $0.20158 before dropping back to $0.14298, with trading volume increasing to $16.88 million
Bitget Pulse2026/03/23 07:05Volatility Brief
In the past 24 hours, BTR price surged from a low of $0.1408 to a high of $0.20158, with a price amplitude of 43.2%. The current quote is $0.14298. The 24-hour trading volume is around $16.88 million, showing amplified activity compared to usual, with a significant proportion coming from futures trading volume.
Brief Analysis of Abnormal Fluctuations
- Multiple price spikes have occurred on the Binance futures platform, accompanied by surging trading volume (such as single spikes reaching 3.58%-5.09%, with trading volume exceeding $440,000 to $630,000).
- The price broke through key moving averages and formed a V-shaped recovery pattern, with traders observing strong volume support and confirmation of higher lows.
Market Views and Outlook
Market sentiment is skewed bullish, with 80% bullish voting on the CMC community (4,200 votes). Several traders have issued long signals with target price levels at $0.190-$0.240, highlighting the potential for further continuation after the breakout. CoinGecko community, on the other hand, has 40% bullish and 60% bearish sentiment, indicating short-term pullback risks.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
